Bone Growth Stimulators Market to Progress at a Substantial CAGR of 5.34% by 2026, as per DelveInsight’s Analysis

The Bone Growth Stimulators market is witnessing a positive market growth owing to the factors such as the prevalence of degenerative bone-related disorders, increasing cases of accident and traumatic cases such as road crashes, sports injuries, and the accumulative focus on developing technologically advanced devices with respect to Bone Growth Stimulators.


Las Vagas, USA, April 12, 2022 (GLOBE NEWSWIRE) -- Bone Growth Stimulators Market to Progress at a Substantial CAGR of 5.34% by 2026, as per DelveInsight’s analysis

The Bone Growth Stimulators market is witnessing a positive market growth owing to the factors such as the prevalence of degenerative bone-related disorders, increasing cases of accident and traumatic cases such as road crashes, sports injuries, and the accumulative focus on developing technologically advanced devices with respect to Bone Growth Stimulators.

DelveInsight's Bone Growth Stimulators Market Insights and Forecast report provides the current and forecast Bone Growth Stimulators Market, upcoming innovations in the devices, individual market shares, challenges, drivers, and barriers, market trends, and key competitors in the Bone Growth Stimulators Market. 

Some of the essential factors from the Bone Growth Stimulators Market report: 

  • As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth and occupy the largest share in the Bone Growth Stimulators market.
  • Key Bone Growth Stimulators companies proactively developing novel devices include names such as Zimmer Biomet, Orthofix Medical Inc., DJO, LLC, Bioventus, ITO Co., Ltd., BTT Health GmbH, Stimulate Health, Kinex Medical Company, LLC, Fintek Bio-Electric Inc., Regen Lab SA, Arthrex, Inc., Altis Biologics (Pty) Ltd, TERUMO BCT, INC., Medtronic, DePuy Synthes (Johnson & Johnson), T-Biotechnology, Dr. PRP USA LLC, Ossatec Benelux BV, and others.
  • DelveInsight analyzes that Global Bone Growth Stimulators Market was valued at USD 1.20 billion in 2020, growing at a CAGR of 5.34% during the forecast period from 2021 to 2026 to reach USD 1.64 billion by 2026.
  • On February 23, 2020, Orthofix announced the approval by the FDA, of an updated version of its bone growth stimulator app, STIM onTrack.
  • On March 7, 2018, Orthofix won FDA approval in the US and CE Mark approval in the European Union for its next-gen PhysioStim bone growth stimulator devices.

To pick on the latest highlights related to Bone Growth Stimulators, get the snapshot of the key highlights entailed in the Bone Growth Stimulators Medical Device Report

Bone Growth Stimulators Overview 

A Bone Growth Stimulator is a device that generates an electric current used to promote bone growth. It uses ultrasonic or pulsed electromagnetic waves. Bone Gowth Stimulators are either external or surgically implanted into the area of the affected bone.

Bone Growth Stimulators Market Insight 

Geographically, the Global Bone Growth Stimulator market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share, North America currently leads the Global Bone Growth Stimulator market and is expected to remain constant during the forecast period.  This domination is attributed due to several factors such as the rising incidents of traumatic injuries due to falls, accidents, and others in the region. Moreover, increasing geriatric and obese people in the region, and rising physician and patient awareness about newly introduced treatment procedures and technologies, rising government initiatives, and increased product launches are expected to aid in the growth of the North America Bone Growth Stimulators Market. 

Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid in the Bone Growth Stimulators market growth in this region.

Click here to understand more about the Bone Growth Stimulators Market Landscape @ Novel Developments In Bone Growth Stimulators Landscape

Bone Growth Stimulators Market Dynamics

The Bone Growth Stimulators market is witnessing a positive market growth owing to the factors such as the prevalence of degenerative bone-related disorders, increasing cases of accident and traumatic cases such as road crashes, sports injuries, and others, the growing burden of the geriatric population who are susceptible to developing various bone degenerative disorders, and the accumulative focus on developing technologically advanced devices with respect to Bone Growth Stimulators. 

However, limited medical reimbursements and the high cost of procedures may be certain limiting factors of the Bone Growth Stimulators market growth. Also, the outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in the reduced number of routine clinical examinations and orthopedic procedures. 

Get a sneak peek at the Bone Growth Stimulators market dynamics @ Bone Growth Stimulators Market Drivers Analysis

Scope of the Bone Growth Stimulators Market Report

  • Coverage: Global
  • Study Period: 2021-2026
  • Market Segmentation By Product Type - Bone Growth Stimulation Devices [Non-Invasive Bone Growth Stimulators {Combined Magnetic Field (CMF) Devices, Capacitive Coupling (CC) Devices, Pulsed Electromagnetic Field (PEMF) Devices, Ultrasonic Bone Growth Stimulators}, Invasive Bone Growth Stimulators], Bone Morphogenetic Proteins (BMP), Platelet-Rich Plasma (PRP)
  • Market Segmentation Based on Application - Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, Others
  • Market Segmentation By End-User - Hospitals, Home Care, Others
  • Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of World
  • Key Bone Growth Stimulators Companies - Zimmer Biomet,  Orthofix Medical Inc., DJO, LLC, Bioventus, ITO Co., Ltd., BTT Health GmbH, Stimulate Health, Kinex Medical Company, LLC, Fintek Bio-Electric Inc., Regen Lab SA, Arthrex, Inc., Altis Biologics (Pty) Ltd, TERUMO BCT, INC., Medtronic, DePuy Synthes (Johnson & Johnson), T-Biotechnology, Dr PRP USA LLC, Ossatec Benelux BV, and others.
  • Porter’s Five Forces Analysis
  • Product Profiles
  • Case Studies 
  • KOL's Views
  • Analyst's View

Delveinsight Analysis: Global Bone Growth Stimulators market was valued at USD 1.20 billion in 2020, growing at a CAGR of 5.34% during the forecast period from 2021 to 2026 to reach USD 1.64 billion by 2026. 

Know more about which MedTech player is set to emerge as the trendsetter @ Key Bone Growth Stimulators Companies Analysis

Table of Contents 

1Bone Growth Stimulators Market Report Introduction
2Bone Growth Stimulators Market Executive summary
3Regulatory and Patent Analysis
4Bone Growth Stimulators Market Key Factors Analysis
5Bone Growth Stimulators Porter’s Five Forces Analysis
6COVID-19 Impact Analysis on Bone Growth Stimulators Market
7Bone Growth Stimulators Market Layout
8Bone Growth Stimulators Market Global Company Share Analysis – Key 3-5 Companies
9Bone Growth Stimulators Market Company and Product Profiles                                                                                                                  
10Project Approach
11KOL Views
12DelveInsight Capabilities
13Disclaimer
14About DelveInsight

Learn more about the report offerings @ Bone Growth Stimulators Regulatory And Patent Analysis

Related Reports

Spinal Fusion Devices Market

Spinal Fusion Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in- depth understanding of market trends, market drivers, market barriers, and key Spinal Fusion Devices companies such as Medtronic, Johnson & Johnson Services, Inc., Zimmer Biomet, Stryker, among others.

Spinal Implants Market

Spinal Implants Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Spinal Implants companies such as Medtronic, Johnson & Johnson, Zimmer Biomet, Stryker Corporation, B. Braun Melsungen AG, among others.

Spinal Non-Fusion Devices Market

Spinal Non-Fusion Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Spinal Non-Fusion Devices companies such as Stryker, NuVasive Inc, Medtronic, Zimmer Biomet, ATEC Spine, Inc, B. Braun Melsungen, SIGNUS Medizintechnik GmbH, among others.

Dental Implants Pipeline

Dental Implants Pipeline Insight and Competitive Landscape 2022 report deliver an in-depth understanding of pipeline devices, Product description, and key Dental Implants companies such as Avinent Implant System S.LU., Cortex Dental Implants Industries Ltd., Dentatus AB, DENTSPLY SIRONA Inc., Envista Holdings Corp., Henry Schein Inc., and others.

Dental Equipment Market

Dental Equipment Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Dental Equipment companies such as DENTSPLY Sirona, Planmeca Group, Envista Holdings, Align Technology, A-dec Inc., among others.

Orthopedic Bone Cement Market 

Orthopedic Bone Cement Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Orthopedic Bone Cement companies such as Aditus Medical, Depuy Synthes, Djo Surgical, Amplitude Surgical, Biopsybell, among others.

Metastatic Bone Pain Pipeline 

DelveInsight’s, “Metastatic Bone Pain – Pipeline Insight, 2021,” report covers the pipeline drug profiles, including clinical and non-clinical stage products, comprehensive insights about 10+ companies, and 10+ pipeline drugs in the Metastatic Bone Pain pipeline landscape including Qilu Pharmaceuticals Co., Ltd, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Progenics Pharmaceuticals, Yong Shun Technology Development, Q.Biomed Inc., Shanghai JMT-Bio Inc, and few others.

Irritable Bowel Syndrome Pipeline

DelveInsight’s, “Irritable Bowel Syndrome (IBS) - Pipeline Insight, 2021,” report covers the pipeline drug profiles, including clinical and non-clinical stage products, comprehensive insights about 24+ companies, and 24+ pipeline drugs in the Irritable Bowel Syndrome pipeline landscape including Arena Pharmaceuticals, 4D Pharma, OrphoMed, Takeda, Biomica, Dong-A ST Co Ltd, Metacrine, MGC Pharma, Napo Pharmaceuticals, Nobilis Therapeutics, Novome Biotechnologies, RQ-00310941, Renexxion, Vitality Biopharma, Oxford Cannabinoid Technologies, and several others.

Bone Metastasis Pipeline

"Bone Metastasis Pipeline Insights, 2021" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Bone Metastasis market. A detailed picture of the Bone Metastasis pipeline landscape, disease overview, commercial assessment, clinical assessment, mechanism of action, clinical studies, and product development activities..

Interested to know more about the breakthrough happenings? Take a look at the posts below 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

 

Contact Data